Cargando…
Optimal Pharmacologic Treatment Strategies in Obesity and Type 2 Diabetes
The prevalence of obesity has increased to pandemic levels worldwide and is related to increased risk of morbidity and mortality. Metabolic comorbidities are commonly associated with obesity and include metabolic syndrome, pre-diabetes, and type 2 diabetes. Even if the prevalence of obesity remains...
Autores principales: | Goswami, Gayotri, Shinkazh, Nataliya, Davis, Nichola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449693/ https://www.ncbi.nlm.nih.gov/pubmed/26237392 http://dx.doi.org/10.3390/jcm3020595 |
Ejemplares similares
-
Behavioral Sciences in the Optimization of Pharmacological and Non-Pharmacological Therapy for Type 2 Diabetes
por: Lopes, António, et al.
Publicado: (2021) -
SAT260 Asymptomatic Vitamin A Toxicity Causing Hypercalcemia
por: Seshan, Nandini, et al.
Publicado: (2023) -
Pharmacologic Treatment Strategies in Children with Type 2 Diabetes
Mellitus
por: Urakami, Tatsuhiko, et al.
Publicado: (2013) -
Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes
por: Munir, Kashif M, et al.
Publicado: (2016) -
ODP026 An Incidental Giant Normotensive Pheochromcytoma with Elevated Metanephrines demonstrated no evidence of hypertensive crisis during a major surgery
por: Camacho, Yudi, et al.
Publicado: (2022)